130 related articles for article (PubMed ID: 27171650)
1. Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma.
Jacobsen BH; Berry JL; Jubran R; Kim JW
Ocul Oncol Pathol; 2015 Dec; 2(2):76-9. PubMed ID: 27171650
[TBL] [Abstract][Full Text] [Related]
2. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
4. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of large spot indirect ophthalmoscopy laser alone or combined with systemic chemotherapy in retinoblastoma therapy].
Liang JH; Cheng Y; Deng X; Yu YY; Li XX
Zhonghua Yan Ke Za Zhi; 2016 Oct; 52(10):745-748. PubMed ID: 27760646
[TBL] [Abstract][Full Text] [Related]
6. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Demirci H; Eagle RC; Shields CL; Shields JA
Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
[TBL] [Abstract][Full Text] [Related]
8. Treatment Outcomes of Focal Laser Consolidation during Chemoreduction for Group B Retinoblastoma.
Kim JW; Aziz HA; McGovern K; Zolfaghari E; Jubran RF; Murphree AL; Berry JL
Ophthalmol Retina; 2017; 1(5):361-368. PubMed ID: 31047562
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
[TBL] [Abstract][Full Text] [Related]
10. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
11. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
12. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
13. High-Resolution Magnetic Resonance Imaging Can Reliably Detect Orbital Tumor Recurrence after Enucleation in Children with Retinoblastoma.
Sirin S; de Jong MC; de Graaf P; Brisse HJ; Galluzzi P; Maeder P; Bornfeld N; Biewald E; Metz KA; Temming P; Castelijns JA; Goericke SL;
Ophthalmology; 2016 Mar; 123(3):635-45. PubMed ID: 26692298
[TBL] [Abstract][Full Text] [Related]
14. Orbital recurrence of retinoblastoma following enucleation.
Kim JW; Kathpalia V; Dunkel IJ; Wong RK; Riedel E; Abramson DH
Br J Ophthalmol; 2009 Apr; 93(4):463-7. PubMed ID: 18757474
[TBL] [Abstract][Full Text] [Related]
15. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma of the Retinal Pigment Epithelium Arising in Conjunction with Late Recurrence and Systemic Metastasis of Retinoblastoma.
Roelofs K; Kherani F; Russell L; Heathcote JG; Weis E
Ocul Oncol Pathol; 2017 Nov; 3(4):296-300. PubMed ID: 29344484
[TBL] [Abstract][Full Text] [Related]
17. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.
Greenwald MJ; Strauss LC
Ophthalmology; 1996 Dec; 103(12):1989-97. PubMed ID: 9003332
[TBL] [Abstract][Full Text] [Related]
18. Managing the consequences of aggressive conservative treatment for refractory retinoblastoma with vitreous seeding.
Brink A; Correa ZM; Geller J; Abruzzo T; Augsburger JJ
Arq Bras Oftalmol; 2014 Aug; 77(4):256-8. PubMed ID: 25410179
[TBL] [Abstract][Full Text] [Related]
19. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
20. Late recurrence of tumor necessitating enucleation in an adult onset retinoblastoma.
Khetan V; Mathur G; Kumar SK; Gopal L
Ophthalmic Genet; 2013; 34(1-2):87-9. PubMed ID: 22950453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
